Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mircera SC Starting Dose in Pediatric CKD Anemia
NCT03552393Phase 2Completed
- Sponsor
- Roche
- Start
- Aug 2018
- Primary completion
- Jul 2021
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 7
01
Overview
A Phase 2 trial of methoxy polyethylene glycol-epoetin beta in anemia of chronic kidney disease (CKD-A), sponsored by Roche. Started Aug 2018; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT03552393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03552393.